Sun Pharmaceutical Industries
Novo Nordisk and Vivtex partner in deal worth up to $2.1bn
The companies aim to develop next-generation oral medicines for obesity and diabetes
Novo Nordisk and Aspect Biosystems expand collaboration on diabetes research
The companies are working together on cellular medicines to boost, replace or repair biological functions
David Weinreich appointed as Merck’s Global Head of R&D and CMO, Healthcare
Weinreich will be based in Billerica, Massachusetts at the company’s Research and Development site
Eli Lilly shares promising phase 3 results for once-weekly insulin candidate efsitora alfa
The company is planning to submit regulatory applications for the candidate by the end of the year
Regeneron gains rights to Hansoh’s GLP-1/GIP receptor agonist in deal worth $2bn
The candidate is being evaluated in a phase 3 obesity trial and phase 2b diabetes study
Eli Lilly announces $3bn expansion to US injectables manufacturing facility
The investment will help Lilly meeting the growing demand for its diabetes and obesity medicines
Sanofi unveils plans to build €1bn insulin production base in China
The site will focus on serving the insulin medication needs of local diabetic patients
Common antidiabetic drug metformin found to slow growth of precancerous cells
The findings suggest that the drug could be used to manage squamous oesophageal cancer risk
Eli Lilly’s once-weekly insulin candidate shows promise in late-stage diabetes trials
It is hoped that a once-weekly treatment option could improve adherence rates
MSD’s Welireg recommended by NICE to treat rare von Hippel-Lindau disease
Approximately one in every 70,000 people are affected by the tumour-causing genetic disease
Merck and Daiichi Sankyo to jointly develop T-cell engager in deal worth over $170m
The partners will evaluate MK-6070 as part of a combination treatment for small cell lung cancer
Merck and Astellas/Pfizer’s bladder cancer combination receives positive CHMP opinion
More than 165,000 new cases of bladder cancer are diagnosed in the EU every year